外籍博士

富康制药主要从事医药制剂、原料药、医药中间体、溴化物、造纸用化学品五大系列六十多个品种的研发、生产和销售。化学原料药中的甲氧苄啶（TMP）的产销量占全球市场销量的70%以上，奥美拉唑、磺胺甲基异噁唑（SMZ）产销量分别居全国首位，是全国最大的溴化物生产企业，溴丙烷、溴氯丙烷、溴化钠、间溴苯甲醚产销量居全国首位，与德国巴斯夫合资企业生产的纸张添加剂ODB-I、ODB-II等产销量居全国首位。
　　Shouguang Fukang Pharmaceutical Co., Ltd. specializes in the development, manufacturing and marketing of 5 core product categories. They are pharmaceutical API, intermediates and finished dose as well as bromide compounds and paper additives, with a total of more than 60 products. Our production and sales volume of the API, trimethoprim (TMP), accounts for more than 70% of the world market. The company is the top domestic producer and marketer of omeprazole, sulfamethoxazole (SMZ) and metformin HCl and the largest production base of bromide compounds. In a joint venture with BASF, we produce the following paper additives ; ODB-II, ODB-I, S-205 and EGTE, to the highest international standards.